SCHEMBL4410841

SCHEMBL4410841

O=C(O)c1cc(-c2ccc(/C=N\Nc3ncc(F)c(N4CCOCC4)n3)o2)ccc1Cl

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 13/20 0.69
▸ MAPT P10636 11/20 0.69
▸ KMT2A Q03164 10/20 0.69
▸ MEN1 O00255 9/20 0.69
▸ POLB P06746 7/20 0.69
▸ NPSR1 Q6W5P4 4/20 0.69
▸ MAPK1 P28482 2/20 0.69
▸ ALDH1A1 P00352 10/20 0.54
▸ GAA P10253 4/20 0.54
▸ HPGD P15428 3/20 0.54
▸ ALOX12 P18054 1/20 0.54
▸ NPC1 O15118 3/20 0.52
▸ RAB9A P51151 3/20 0.52
▸ TDP1 Q9NUW8 5/20 0.52
▸ BLM P54132 1/20 0.52
▸ KDM5A P29375 1/20 0.51
▸ L3MBTL1 Q9Y468 4/20 0.46
▸ RECQL P46063 2/20 0.46
▸ PKM P14618 2/20 0.46
▸ CTDSP1 Q9GZU7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14537664 0.93 MAPT (0.68) KDM4EMAPTKMT2AMEN1POLB
SCHEMBL14536216 0.88 MAPT (0.72) KDM4EMAPTKMT2AMEN1POLB
SCHEMBL13548901 0.86 MAPT (0.68) KDM4EMAPTKMT2AMEN1POLB
SCHEMBL4408424 0.85 MAPT (0.68) KDM4EMAPTKMT2AMEN1POLB
SCHEMBL8239298 0.80 KMT2A (0.60) KDM4EMAPTKMT2AMEN1POLB
SCHEMBL4404072 0.79 MAPT (0.70) KDM4EMAPTKMT2AMEN1POLB
SCHEMBL13550625 0.76 KDM5A (0.49) KDM4EMAPTKMT2AMEN1POLB
SCHEMBL13548879 0.73 KDM5A (0.74) KDM4EMAPTKMT2AMEN1POLB
SCHEMBL12113861 0.72 GAA (0.87) KDM4EMAPTKMT2AMEN1POLB
SCHEMBL8241062 0.72 MAPT (0.56) KDM4EMAPTKMT2AMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11839617-B2 Theramutein modulators HMI Medical Innovations, LLC (US) 2023-12-12 — — US disclosed
US-11839617-B2 Theramutein modulators HMI Medical Innovations, LLC (US) 2023-12-12 — — US disclosed
US-11714080-B2 Compounds and methods of identifying, synthesizing, optimizing and profiling protein modulators HMI Medical Innovations, LLC (US) 2023-08-01 — — US disclosed
US-11692998-B2 Compounds and methods of identifying, synthesizing, optimizing and profiling protein modulators HMI Medical Innovations, LLC (US) 2023-07-04 — — US disclosed
US-11692998-B2 Compounds and methods of identifying, synthesizing, optimizing and profiling protein modulators HMI Medical Innovations, LLC (US) 2023-07-04 — — US disclosed
US-20210215670-A1 COMPOUNDS AND METHODS OF IDENTIFYING, SYNTHESIZING, OPTIMIZING AND PROFILING PROTEIN MODULATORS HMI Medical Innovations, LLC 2021-07-15 — — US disclosed
US-20210215671-A1 COMPOUNDS AND METHODS OF IDENTIFYING, SYNTHESIZING, OPTIMIZING AND PROFILING PROTEIN MODULATORS HMI Medical Innovations, LLC 2021-07-15 — — US disclosed
US-10955408-B2 Compounds and methods of identifying, synthesizing, optimizing and profiling protein modulators HMI Medical Innovations, LLC (US) 2021-03-23 — — US disclosed
US-20210015825-A1 THERAMUTEIN MODULATORS HMI Medical Innovations, LLC 2021-01-21 — — US disclosed
US-20210008077-A1 THERAMUTEIN MODULATORS HMI Medical Innovations, LLC 2021-01-14 — — US disclosed
US-20100016298-A1 Theramutein modulators HOUSEY GERAD M 2010-01-21 — — US disclosed
US-20100016298-A1 Theramutein modulators HOUSEY GERAD M 2010-01-21 — — US disclosed
US-20090275070-A1 Compounds and Methods of Identifying, Synthesizing, Optimizing and Profiling Protein Modulators HOUSEY GERARD M 2009-11-05 — — US disclosed
US-20090275070-A1 Compounds and Methods of Identifying, Synthesizing, Optimizing and Profiling Protein Modulators HOUSEY GERARD M 2009-11-05 — — US disclosed
US-20080269262-A1 Blocking or activation of endogenous proteins variations rncoded by mutated gees HMI MEDICAL INNOVATIONS, LLC. 2008-10-30 — — US disclosed
US-20080269262-A1 Blocking or activation of endogenous proteins variations rncoded by mutated gees HMI MEDICAL INNOVATIONS, LLC. 2008-10-30 — — US disclosed
WO-2008091681-A2 THERAMUTEIN MODULATORS HOUSEY GERARD M (US) 2008-07-31 — — WO disclosed
US-20070111199-A1 Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators HMI Medical Innovations, LLC 2007-05-17 — — US disclosed
US-20070111199-A1 Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators HMI Medical Innovations, LLC 2007-05-17 — — US disclosed
WO-2007037898-A2 THERAMUTEIN MODULATORS HOUSEY PHARMACEUTICALS INC (US) 2007-04-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210008077-A1 THERAMUTEIN MODULATORS TSG101, SERPINE1, PLAUR KDM4E 4221/4885MAPT 2984/4885KMT2A 3567/4885
US-20100016298-A1 Theramutein modulators TSG101, SERPINE1, PLAUR KDM4E 4221/4885MAPT 2984/4885KMT2A 3567/4885
US-20210015825-A1 THERAMUTEIN MODULATORS TSG101, SERPINE1, PLAUR KDM4E 4221/4885MAPT 2984/4885KMT2A 3567/4885
US-11839617-B2 Theramutein modulators TSG101, SERPINE1, PLAUR KDM4E 4221/4885MAPT 2984/4885KMT2A 3567/4885
US-20080269262-A1 Blocking or activation of endogenous proteins variations rncoded by mutated gees SERBP1, SERPINA6, UBE2V1 KDM4E 4172/4885MAPT 4644/4885KMT2A 4448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback